| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.39 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |